Definium Therapeutics, Inc. (DFTX)
17.66
+0.11
(+0.63%)
USD |
NASDAQ |
Mar 06, 16:00
17.69
+0.03
(+0.17%)
After-Hours: 20:00
Definium Therapeutics Cash from Investing (TTM) : -151.92M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Pulse Biosciences, Inc. | -0.335M |
| RxSight, Inc. | 16.89M |
| Plus Therapeutics, Inc. | 0.287M |
| Viridian Therapeutics, Inc. | -37.56M |
| Nutriband, Inc. | -0.0053M |